CA
NZ
UK
AU
IND
US
GeoVax Labs, Inc. The clinical‑stage biotechnology firm also reported earnings per share of $-0.97, substantially better than the $-2.94 consensus estimate. This performance arrives as the company advances its core development programs, including the GEO‑MVA vaccine and the Gedeptin immuno‑oncology therapy.
Johnson & Johnson (NYSE: JNJ) has proposed a $5.5 billion comprehensive settlement to resolve its ongoing talc litigation, which has faced significant scrutiny over the years. This initiative follows a favorable ruling from the federal Multi-District Litigation (MDL) court, where judges indicated that plaintiffs …
MapLight Therapeutics, Inc. (NASDAQ: MPLT) faces significant pressure in the market, with insider officers having liquidated shares worth $6.7 million over the past two months. This selling activity, taking place across 21 transactions, raises concerns about the sentiment from current management amid a challenging …
Erasca, Inc. stands in the spotlight as it faces a class action securities lawsuit with a significant deadline looming on August 10, 2026. The case targets investors who purchased shares within the time frame of January 14, 2025, to April 26, 2026, accusing the …
GE HealthCare Technologies Inc. (GEHC) posted second-quarter earnings that fell short of analysts' expectations, reporting an earnings per share (EPS) of $0.99 against a consensus estimate of $1.07. While the figure marks a setback, the company's share price climbed 1.8% to $61.68, a noteworthy …
Argenx Announces $2.2bn Cash Deal for Forte Biosciences
The bipartisan National Commission on Local Public Health Leadership introduced a comprehensive plan on July 27 designed to reinforce municipal health agencies and the officials who oversee them. The strategy calls for five coordinated steps that prioritize localized data networks and steady supplies of …
Neumora Therapeutics (NASDAQ: NMRA) disclosed clean repeat‑dose toxicology findings for its brain‑penetrant NLRP3 inhibitor NMRA‑215, a program targeting obesity and related cardiometabolic conditions. The company wrapped up a follow‑up toxicology program in rodents after earlier investigations raised audit considerations. Across the study, no unforeseen …
Precision BioSciences Inc (NASDAQ: DTIL) has announced significant changes to its executive leadership team, appointing Alex Kelly as Chief Operating Officer and Naresh Tanna as Chief Financial Officer. Mr. Kelly's compensation includes an annual base salary of $510,000, along with a target annual bonus …
Service Coordination, Inc. has taken a significant step in its leadership structure by appointing Amy Floria as its new Chief Financial Officer as of July 27, 2026. Floria, who has more than three decades of experience in finance, healthcare operations, quality assurance, and strategic …
Please wait processing your request...